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Recent studies have shown that the formation of myringosclerosis could be reduced by the 
application of antioxidant enzymes and elements.
Objective: The aim of this study was to investigate the effectiveness of coenzyme Q10 on the 
prevention of experimentally induced myringosclerosis.
Method: Forty-eight healthy female wistar albino rats were bilaterally myringotomized and divided 
into four groups randomly. Group A received no treatment, group B was administered oral coenzyme 
Q10. Group C was treated with topical saline solution, group D received topically coenzyme Q10. On 
the 15th day of treatment, tympanic membranes were examined by otomicroscopy. Myringosclerotic 
lesions were documented semiquantitatively by using 4-point scale. After harvesting tympanic 
membranes were evaluated histopathologically.
Results: In group D (topical coenzyme Q10), we observed otitis within the first four days of the 
study and this group was excluded from the study. Regarding otomicroscopic examinations, there 
were no significant differences among groups in myringosclerosis formation (p = 0.241). When 
group A (non treatment) compared to groups B and C regarding histopathologic examination, the 
results demonstrated statistical significant differences (p = 0.004; p < 0.001), respectively. There was 
no statisticaly significant difference between groups B and C (p = 0.160).
Conclusion: Oral administration of coenzyme Q10 did not reduce myringosclerosis formation in 
myringotomized rats.
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INTRODUCTION
Tympanosclerosis is a degenerative process in the 
connective tissue layer and effects both the tympanic 
membrane (TM) and the middle ear mucosa1,2. The most 
common localization of tympanosclerosis is in the TM 
and called myringosclerosis (MS)1. It is hyalinization 
and calcification of the collagen layer in certain areas of 
the TM3-6. Histologically, there is an increase in collagen 
fibers due to progressive fibroblast infiltration as well as 
hyaline degeneration and extracellular calcium deposi-
tion within lamina propria2-4. It appears as semicircular 
crescent or horseshoe-shaped white chalky patches usu-
ally at the anterior and posterior inferior quadrants of 
the TM6. Myringosclerosis (MS) is a common sequele of 
recurrent otitis media, otitis media with effusion, chronic 
otitis media and ventilation tube insertion3-5. Although the 
morphology of MS has been well described, the exact eti-
ology and pathogenesis is still inadequately understood. 
Several hypotheses have been proposed for the etiology 
of MS including: reactive oxygen species, immunologic 
sensitivity, mechanical injury, metabolic disturbance and 
inflammatory reaction3,7-9.
Coenzyme Q10 (CoQ10) is regenerable, bioener-
getic, powerful, intracellular antioxidant10,11. It exists in 
all cells and is endogenously synthesized as well as food 
intake11,12. It acts as an electron and proton carrier in the 
mitochondrial respiratory chain and is necessary for ATP 
production10. It protects phospholipids and mitochondrial 
membrane proteins from peroxidation and protects DNA 
against the oxidative damage that accompanies lipid 
peroxidation11. CoQ10 functions as an antioxidant, sup-
porting the regeneration of other antioxidant; influencing 
the stability, fludity and permeability of membranes; and 
stimulating cell growth and inhibiting cell death12. It is 
present in the body in both the reduced (ubiquinol) and 
oxidised (ubiquinone) forms13. Its reduced form, ubiqui-
nol is also an antioxidant10. When cell membranes are 
oxidized, ubiquinol is the first antioxidant consumed14. 
Moreover, the formation of oxidized lipids and the con-
sumption of α-tocopherol are suppressed while ubiquinol 
is present14.
Recent studies have shown that the formation of 
MS, after experimental myringotomy, could be reduced by 
the application of antioxidant enzymes and elements1,3. In 
the light of these studies, we also thought that MS might 
be reduced or prevented by the application of the anti-
oxidant CoQ10.
The aim of this study was to investigate possible 
preventive effect of CoQ10 on the development of MS in 
the TM of myringotomized rats using otomicroscopy and 
histopathology. To our knowledge, this is the first study to 
evaluate the preventive effect of topical and oral adminis-
tration of CoQ10 on the development of MS.
METHOD
Experimental Design
The experimental design was approved by the 
Ethics Research Committee in Animal Experiments (prot. 
nº: 31/03/2010-60/308), and this study was conducted in 
compliance with the guidelines for animal experimentation 
at the department of Laboratory Animal Science of Medical 
School. All animals care and procedures were performed 
humanely. The animals were kept in ordinary cages with 
free access to food and water and at a temperature of 20 
to 22°C with artificial lighting in a period of 12 hours. 
They were given pellets (2700 ME Kcal/kg, 23% HP) and 
water ad libitum and used after 1 week of quarantine and 
acclimatization.
Forty-eight healthy female wistar albino rats, mean 
weight 220 g, were used in this study. The animals that had 
external or middle ear infection and adhesion, perforation, 
or retraction in the TM during otomicroscopic examination 
were excluded from the study. They were anesthetized 
by ketamine hydrocloride (50 mg/kg, intramuscular). 
Myringotomies were performed bilaterally in the posterior 
superior quadrant of TMs through an ear speculum with 
sterile pic under the otomicroscope (Opmi 1, Zeiss, Ger-
many). No intratympanic bleeding was observed during 
this procedure.
The rats were separated into four groups randomly 
(groups A, B, C, D). Each group included 12 rats. Group 
A served as the control group and were not administered 
treatment. In group B, animals received 100 mg/kg/day 
CoQ10 with feeding needle and group C received 0.1 ml 
saline solution topically in both ears. Group D received 
100 mg/kg/day CoQ10 (GNC 50 mg soft gelatine capsul 
diluted with 0.2 ml saline) topically in both ears. Saline 
solution and CoQ10 diluted with saline were dropped 
into external ear canal using a syringe. The medicine was 
administered daily for 15 days. The dose of the CoQ10 
supplement was determined according to the literature14. 
Two TMs of another rat were served for histopathologic 
comparison between the TMs of study groups and the 
healthy intact TM7. TMs of anesthetized rats were exam-
ined by otomicroscopy on the 15th day after treatment. The 
status of TMs was evaluated and myringosclerotic lesions 
were documented semiquantitatively by using 4-point 
scale: (0), no visible myringosclerotic plaques; (1), oc-
casional MS with white halo around umbo; (2), moderate 
MS with white halo around umbo and white line beside 
the handle of the malleus and along the annulus; and 
(3), severe MS with confluent whitish deposits, forming a 
horseshoe shaped pattern15.
Histopathologic Evaluation
On the 15th day, the rats were sacrificed painlessly 
by high dose pentobarbital (80 mg/kg, intraperitoneal 
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injection). TM and surrounding bony annulus were 
removed together. They were fixed with 10 percent 
formaldehyde solution and decalcified with 7 percent 
nitric oxide solution. The specimens were embedded 
paraffin. After routine processing, the specimens were 
sectioned on 4 µm thick. Sections were prepared at the 
level of pars tensa where myringotomies were performed 
and stained with hematoxylin-eosin and toluidine blue. 
Toluidine blue staining was used to evaluate the sclerotic 
changes in the connective tissue of lamina propria. In 
the light microscope, stained specimens were evaluated 
by blinded pathologist according to degree of sclerosis, 
hyalinization and intensity of fibroblastic proliferation in 
the lamina propria and thickness of TM. They were docu-
mented by comparing TM of normal rat and using 5 point 
scale from 0 (normal) to 4. The groups were compared 
according to findings of otomicroscopic and histopatho-
logic examinations.
Statistical Analysis
Statistical analysis was performed by Statistical 
Package for Social Sciences (SPSS) 11.5 software (SPSS 
Inc., Chicago, IL, United States). Data were expressed as 
median (minimum-maximum) for ordinal data and number 
of cases and percentages for nominal variables. The me-
dian differences among group were analyzed by Kruskal 
Wallis test. When the p-value from the Kruskal Wallis test 
are statistically significant to know which group differ from 
which others by using Conover’s multiple comparison 
test were used. Nominal data were evaluated by Pearson 
Chi-square or Fisher’s exact test, where appropriate. A p 
value less than 0.05 was considered statistically significant.
RESULTS
Excluded group because of otitis and death
Two rats (1/B, 1/C) died because of natural causes 
at the end of the study. In group D (topical), we observed 
otitis within the first four days of the study and this group 
was excluded from the study. In otomicroscopic examina-
tion because of otitis media, 5 ears (2/A, 1/B, 2/C) and in 
histopathologic examination 1 additional ear (1/C) were ex-
cluded from the study. Consequently, total 6 ears and group 
D (topical) were excluded from the study because of otitis.
Otomicroscopic examination
All TM perforations in four groups were healed. 
Table 1 summarizes the results of otomicroscopic exami-
nation. When statistical analysis was evaluated according 
to otomicroscopic examinations, there were no significant 
differences among groups in MS formation (p = 0.241). 
According to otomicroscopic and histopathologic evalu-
ations, comparison of median values among groups is 
shown in Table 2.
Histopathologic examination
Normal TMs, were thin and free of inflammatory 
cells (Figure 1). There were extensive sclerotic lesions and 
intensity of fibroblasts located in the lamina propria and 
increased thickness of the TM in groups B (oral), C (saline) 
(Figures 2, 3). The TMs from group A (non treatment) 
were thinner than those from groups B (oral), C (saline) 
and the fibroblastic activity in lamina propria and sclerotic 
lesions were also less pronounced in this group. Accord-
ing to groups the findings of histopathologic examination 
were shown in Table 3. When group A (non treatment) 
compared to groups B (oral) and C (saline) regarding histo-
pathologic examination, the results demonstrated statistical 
significant differences (p = 0.004; p < 0.001), respectively. 
There was no statisticaly significant difference between 
groups B (oral) and C (saline) (p = 0.160).
Table 1. Otomicroscopic examination of sclerotic lesions.
Groups Ears
Myringosclerosis scale (point)
0 1 2 3
A (non treatment) 22 3 8 11 0
B (oral CoQ10) 21 1 6 14 0
C (saline) 19 3 3 9 4
CoQ10: Coenzyme Q10.
Table 2. Comparison of median values in otomicroscopic and 
histopathologic examinations.
Groups and ears Otomicroscopic Histopathologic
A (non treatment) 22 1.5 (0-2) 1 (0-4)
B (oral CoQ10) 21 2 (0-2) 2 (0-4)
C (saline) 19 2 (0-3) 3 (1-4)
p value 0.241 < 0.001
Data were expressed as median (minimum-maximum); CoQ10: Co-
enzyme Q10.
Figure 1. Appearence of normal tympanic membrane (0 point scale) in 
group A (hematoxylin and eosin, original magnification x100).
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DISCUSSION
Recent studies emphasized that oxygen-derived free 
radicals, mechanical injury and an inflammatory disease may 
be the main factors in the formation of MS8,9. Mattsson et al.9 
observed that MS lesions were shown to increase in number 
with increased oxygen concentrations when myringotomized 
rats were exposed to different oxygen concentrations and 
suggested that the mechanism involved could be related to 
the formation of oxygen radicals. The myringotomy permits 
passage of ambient air into the middle ear cavity resulting 
in a relatively hyperoxic condition. This condition would 
lead to an increased oxygenation of the tissues, and could 
provoke an increased production of oxygen-derived free 
radicals, which may trigger irreversible tissue damage involv-
ing fibrosis, hyaline degeneration as seen in MS9.
There have been many experimental studies at-
tempting to prevent the development of MS by applying 
free radical scavengers topically or systematically3-5,7,15,16. It 
was reported that topically applied free radical scavengers 
such as ascorbic acid15, N-acetylcysteine16, copper zinc-
superoxide dismutase plus catalase and deferoxamine 
inhibited the development of MS6. On the other hand, 
previous studies also noticed that systematically adminis-
tered L-carnitine17, selenium5, caffeic acid phenethyl ester3, 
vitamin E (alpha-tocopherol)4, gingko biloba7 were effec-
tive to prevent MS formation. In addition to, Polat et al.1 
demonstrated that both topical and intramuscular appli-
cation of vitamin E reduces the formation of MS and the 
reactive oxygen species in TMs. Consequently, the findings 
of reports have supported the hypothesis that the forma-
tion of reactive oxygen species contributed significantly 
to the development of MS1,15.
It was found that the development of MS after myr-
ingotomy can be arrested by antiinflammatory drugs such 
as the dexametason or topical fenspiride.8 Some agents 
reduced the development of MS have both antioxidant 
and anti-inflammatory effects3,7,16.
In group D (topical), we observed otitis although 
previous animal studies did not report that topically 
applied agents caused otitis and/or had irritative effect 
in TM1,15,16. Possible chemical irritative effect of topically 
applied CoQ10 might cause inflammation in the TMs. 
We thought that topical CoQ10 application had possible 
chemical irritative effect in TM.
Figure 2. In tympanic membrane evaluated as 4 point scale from 
group B, the fibroblast proliferation, markedly increased of membra-
ne thickness, sclerotic changes are shown (toluidine blue, original 
magnification x200).
Figure 3. In tympanic membrane evaluated as 2 point scale from group 
C, moderately thickened and sclerotic plaque are shown (toluidine 
blue, original magnification x200).
Table 3. The findings of histopathologic examination of TMs.
Groups Ears
Histopathologic Scale
0 1 2 3 4
A (non treatment) 22 1 12 6 2 1
B (oral CoQ10) 21 3 0 8 8 2
C (saline) 19 0 2 4 10 3
TMs: Tympanic membranes; CoQ10: Coenzyme Q10.
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Mattsson et al.8 reported that the observation of MS 
in the otomicroscope did not completely corroborate the 
findings in the light microscope.
Though many agents are proven to prevent the 
development of MS in experimental studies, there are 
no standardized objective findings in the histopathologic 
evaluation of MS2. We also used 5 point scale from (0) 
to (4) by evaluating degree of sclerosis, hyalinization, 
intensity of fibroblastic proliferation and thickness of TM. 
In some earlier studies, the agents that reduced the devel-
opment of MS led to unwanted thickening of the TM due 
to an increased number of fibroblasts in histopathologic 
evaluation5,15,16. Contrary to these studies, some authors 
observed that there was a positive relationship between 
thickness of TM and degree of MS2-4,7,17. Our results were 
also similar to these literature findings.
CoQ10 is a relatively large, hydrophobic molecule. 
Therefore, absorption of CoQ10 into tissues is often slow 
and limited12. Tissues with high energy requirements, such 
as the heart, kidney, liver and skeletal muscle, contain high 
amounts of CoQ1010. It was suggested that there were pos-
sible discrepancies between extracellular and intracellular 
CoQ10 concentrations11.
CONCLUSION
In this investigation, it was found that sistemic 
CoQ10 administration for 15 days to myringotomized rats 
were not effective to prevent the development of MS. In 
this context, inefficacy due to dose and duration of applied 
CoQ10 may be reviewed. Although we could not measure 
plasma levels of CoQ10, we confirmed that dose and dura-
tion of administered CoQ10 in this study provided efficient 
antioxidant effect regarding to these literature11,12,18,19.
Concerning ineffectiveness of CoQ10 on MS, we 
have speculated that CoQ10 would have unclear mecha-
nism on the development of MS.
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